NCT00571610已完成1 期
A Single-Center, Open-Label, Single-Arm Pilot Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Implantable Device Used to Reduce Mitral Valve Regurgitation.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Viacor
- 入组人数
- 5
- 试验地点
- 2
- 主要终点
- percent of patients who remain free from device-related major adverse events (death, myocardial infarction, tamponade, emergent cardiac surgery
研究概览
简要总结
Reduction in mitral regurgitation due to safe placement of a PTMA device in the coronary sinus.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Functional MR 2+ - 4+ with left ventricular enlargement
- •Symptomatic heart failure
- •20% - 50% LVEF
排除标准
- •mitral regurgitation of organic origins
- •recent cardiac interventions
- •severe comorbidities
结局指标
主要结局
percent of patients who remain free from device-related major adverse events (death, myocardial infarction, tamponade, emergent cardiac surgery
时间窗: 30 days
次要结局
- percent of implanted patients who maintain a sustained 1 grade reduction in MR and reduction of mitral annulus anterior posterior dimension(30 days)
- percent of implanted patients who exhibit improvement of clinical symptoms as one of the following: decrease in NYHA class, improvement of Minnesota QOL survey, increase exercise capacity 6 minute walk or improvement in VO2 max(30 days)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Mitral Valve SurgeryMitral Valve DiseaseNCT03697941Karolinska University Hospital268
已完成
1 期
Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral RegurgitationHeart FailureMitral RegurgitationNCT00572091Viacor4
已完成
1 期
Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral RegurgitationHeart FailureMitral RegurgitationNCT00568230Viacor12
招募中
不适用
Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients With Mitral Valve Disease (TORCH-M)Mitral Valve DiseaseNCT04954404Second Affiliated Hospital, School of Medicine, Zhejiang University2,000
Enrolling By Invitation
不适用
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Degenerated Mitral RegurgitationDegenerated Mitral RegurgitationNCT06467110Shanghai Shenqi Medical Technology Co., Ltd118
